Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Evidence- |
RCV000495801 | SCV000578394 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 1 | 2017-06-29 | reviewed by expert panel | curation | Synonymous substitution variant, with low bioinformatic likelihood to result in a splicing aberration (Splicing prior probability 0.02; http://priors.hci.utah.edu/PRIORS/). |
Ambry Genetics | RCV000213501 | SCV000278238 | likely benign | Hereditary cancer-predisposing syndrome | 2015-09-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000615805 | SCV000716291 | likely benign | not specified | 2017-02-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Color Diagnostics, |
RCV000213501 | SCV000904130 | likely benign | Hereditary cancer-predisposing syndrome | 2018-04-19 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000615805 | SCV000918762 | likely benign | not specified | 2019-08-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001481455 | SCV001685800 | likely benign | Hereditary breast ovarian cancer syndrome | 2024-04-01 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000495801 | SCV004815676 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 1 | 2023-12-01 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV000977545 | SCV001551797 | uncertain significance | not provided | no assertion criteria provided | clinical testing |